EXCELLtoINNOV SIGNED
Leverage research EXCELLence and INNOVation potential of Instituto de Medicina Molecular (IMM) through translational biomedical research in immunity and infection.
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0EXCELLtoINNOV project word cloud
Explore the words cloud of the EXCELLtoINNOV project. It provides you a very rough idea of what is the project "EXCELLtoINNOV" about.
Project "EXCELLtoINNOV" data sheet
The following table provides information about the project.
| Coordinator |
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES
Organization address contact info |
| Coordinator Country | Portugal [PT] |
| Project website | https://imm.medicina.ulisboa.pt/pt/imm-lisboa/projectos-internacionais/excelltoinnov/ |
| Total cost | 2˙777˙183 € |
| EC max contribution | 2˙499˙465 € (90%) |
| Programme |
1. H2020-EU.4.c. (Establishing ‚ERA Chairs') |
| Code Call | H2020-WIDESPREAD-2014-2 |
| Funding Scheme | CSA |
| Starting year | 2015 |
| Duration (year-month-day) | from 2015-07-01 to 2020-06-30 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES | PT (LISBOA) | coordinator | 2˙499˙465.00 |
Map
Project objective
EXCELLtoINNOV will provide IMM with the needed means to achieve excellence on a sustainable basis through the recruitment of an ERA Chair in translational biomedical research in immunity and infection. This goal will be strategically achieved by placing IMM in the forefront of Research, Development and Innovation (R&DI) in immunity and infection, through the establishment of a translational biomedical research hub anchored in Lisbon that will: i. leverage the national potential beyond borders; ii. act as the interface of Europe with America and Africa; iii. and effectively contribute to overcome the health and demographic change societal challenges by potentiating major scientific advancements in this research area through worldwide collaborative efforts. The successful implementation of this strategy will be possible through specific activities, including: 1) the development of a new research field at IMM by the ERA Chair holder, pre-clinical molecular and imaging studies, that will transversally benefit and impact all research areas at IMM; 2) the implementation of structural changes at IMM to successfully support and comply with ERA priorities; 3) the expansion of overseas collaborations in international collaborative R&DI projects; and 4) an improved integration of IMM in the regional, national and international business community. Through the completion of these activities we will achieve an improved capability to compete successfully for internationally competitive research funding, including but not limited to Horizon 2020, IMI2 and EDCTP2 as well as effectively contribute to the objectives of regional smart specialisation strategies through increased international attractiveness, competitiveness and innovation potential of IMM, Lisbon and Portugal.
Deliverables
| Organisation of thematic Workshops – second period | Documents, reports | 2020-04-07 19:51:59 |
| Publications in the research field of immunity and infection of the Instituto de Medicina Molecular | Documents, reports | 2020-04-07 19:51:59 |
| Brochure and flyer development | Websites, patent fillings, videos etc. | 2020-04-07 19:51:59 |
| Development of the project logo/brand | Websites, patent fillings, videos etc. | 2020-04-07 19:51:59 |
| Organisation of thematic Workshops – first period | Documents, reports | 2020-04-07 19:51:59 |
| Launch of website | Websites, patent fillings, videos etc. | 2020-04-07 19:51:59 |
| Acquisition of the pre-clinical molecular and imaging equipment | Documents, reports | 2020-04-07 19:51:59 |
| Forum for overseas discussion in translational immunity and infection | Websites, patent fillings, videos etc. | 2020-04-07 19:51:59 |
Take a look to the deliverables list in detail: detailed list of EXCELLtoINNOV deliverables.
Publications
| year | authors and title | journal | last update |
|---|---|---|---|
| 2017 |
Marc Veldhoen Interleukin 17 is a chief orchestrator of immunity published pages: 612-621, ISSN: 1529-2908, DOI: 10.1038/ni.3742 |
Nature Immunology 18/6 | 2020-04-07 |
| 2017 |
Å pela Konjar, Cristina Ferreira, Birte Blankenhaus, Marc Veldhoen Intestinal Barrier Interactions with Specialized CD8 T Cells published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2017.01281 |
Frontiers in Immunology 8 | 2020-04-07 |
| 2018 |
Å pela Konjar, Birte Blankenhaus, Marc Veldhoen Oxygen starvation during T cell priming boosts cancer-killing potential published pages: S34-S37, ISSN: 2218-676X, DOI: 10.21037/tcr.2017.12.07 |
Translational Cancer Research 7/S1 | 2020-04-07 |
| 2018 |
Marc Veldhoen, Birte Blankenhaus, Å pela Konjar, Cristina Ferreira Metabolic wiring of murine TÂ cell and intraepithelial lymphocyte maintenance and activation published pages: , ISSN: 0014-2980, DOI: 10.1002/eji.201646745 |
European Journal of Immunology | 2020-04-07 |
| 2017 |
Verena Brucklacher-Waldert, Cristina Ferreira, Marisa Stebegg, Olivier Fesneau, Silvia Innocentin, Julien C. Marie, Marc Veldhoen Cellular Stress in the Context of an Inflammatory Environment Supports TGF-β-Independent T Helper-17 Differentiation published pages: 2357-2370, ISSN: 2211-1247, DOI: 10.1016/j.celrep.2017.05.052 |
Cell Reports 19/11 | 2020-04-07 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EXCELLTOINNOV" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "EXCELLTOINNOV" are provided by the European Opendata Portal: CORDIS opendata.